Making the Case for CGM Use in the Hospital During COVID-19
During the COVID-19 pandemic, appropriate implementation of continuous glucose monitoring (CGM) in...
Read More
Diabetes
Conference Highlights: ADA 2020
New research was presented at ADA 2020, the virtual 80th Scientific Sessions of American Diabetes...
Read More
The Changing Profile of Liver Disease
With significant advances in the treatment of viral hepatitis—including increasing cure rates for...
Read More
Diabesity: The Tricky Devil in times of COVID-19
We are fighting multiple health devils in our daily lives. While COVID-19 is the most recent one,...
Read More
Nonnutritive Sweetener Use in Children
Nonnutritive sweeteners (NNSs)—also known as non-caloric artificial sweeteners or high-intensity...
Read More
CME: Intensive Glucose-Lowering Therapy & Hypoglycemia
This course reviews the number of ED visits and hospitalizations specifically due to intensive...
Read More Intensive Glucose-Lowering Therapy & Hypoglycemia
Prior research indicates that hypoglycemia is a frequently occurring byproduct of intensive...
Read More
Time in Range: Eclipsing A1C in Glucose Management
In January 2020, the American Diabetes Association (ADA) released its annual Standards of Medical...
Read MoreN-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract.
N-methyladenosine (mA) is the most prevalent eukaryotic messenger RNA modification. Diabetic cataract (DC) is caused by high glucose (HG) in diabetes mellitus. However, the regulatory mechanism of mA in the DC pathogenesis is...
Read More